axcelis technologies - ACLS
ACLS
Close Chg Chg %
95.51 -0.42 -0.44%
Closed Market
95.09
-0.42 (0.44%)
Volume: 353.63K
Last Updated:
Apr 2, 2026, 4:00 PM EDT
Company Overview: axcelis technologies - ACLS
ACLS Key Data
| Open $91.78 | Day Range 91.78 - 96.78 |
| 52 Week Range 40.40 - 102.93 | Market Cap $2.92B |
| Shares Outstanding 30.72M | Public Float 30.30M |
| Beta 1.65 | Rev. Per Employee N/A |
| P/E Ratio 25.04 | EPS $3.81 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 737.34K |
ACLS Performance
| 1 Week | -2.32% | ||
| 1 Month | 15.63% | ||
| 3 Months | 10.42% | ||
| 1 Year | 124.16% | ||
| 5 Years | 99.77% |
ACLS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
7
Full Ratings ➔
About axcelis technologies - ACLS
Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training. The company was founded in 1978 and is headquartered in Beverly, MA.
ACLS At a Glance
Axcelis Technologies, Inc.
108 Cherry Hill Drive
Beverly, Massachusetts 01915-1088
| Phone | 1-978-787-4000 | Revenue | 839.05M | |
| Industry | Industrial Machinery | Net Income | 120.24M | |
| Sector | Producer Manufacturing | Employees | 1,465 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
ACLS Valuation
| P/E Current | 25.045 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 21.16 |
| Price to Sales Ratio | 3.032 |
| Price to Book Ratio | 2.385 |
| Price to Cash Flow Ratio | 21.51 |
| Enterprise Value to EBITDA | 16.372 |
| Enterprise Value to Sales | 2.672 |
| Total Debt to Enterprise Value | 0.032 |
ACLS Efficiency
| Revenue/Employee | 572,729.01 |
| Income Per Employee | 82,073.72 |
| Receivables Turnover | 4.98 |
| Total Asset Turnover | 0.619 |
ACLS Liquidity
| Current Ratio | 4.772 |
| Quick Ratio | 3.107 |
| Cash Ratio | 1.893 |
ACLS Profitability
| Gross Margin | 44.914 |
| Operating Margin | 14.22 |
| Pretax Margin | 16.477 |
| Net Margin | 14.33 |
| Return on Assets | 8.873 |
| Return on Equity | 11.745 |
| Return on Total Capital | 10.867 |
| Return on Invested Capital | 11.029 |
ACLS Capital Structure
| Total Debt to Total Equity | 6.939 |
| Total Debt to Total Capital | 6.489 |
| Total Debt to Total Assets | 5.274 |
| Long-Term Debt to Equity | 6.318 |
| Long-Term Debt to Total Capital | 5.908 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Axcelis Technologies - ACLS
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 920.00M | 1.13B | 1.02B | 839.05M | |
Sales Growth
| +38.88% | +22.89% | -9.97% | -17.57% | |
Cost of Goods Sold (COGS) incl D&A
| 518.21M | 639.30M | 563.21M | 462.20M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 11.61M | 13.07M | 15.81M | 17.61M | |
Depreciation
| 11.61M | 13.07M | 15.81M | 17.61M | |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| +39.22% | +23.37% | -11.90% | -17.93% | |
Gross Income
| 401.79M | 491.30M | 454.65M | 376.85M | |
Gross Income Growth
| +38.45% | +22.28% | -7.46% | -17.11% | |
Gross Profit Margin
| +43.67% | +43.45% | +44.67% | +44.91% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 189.43M | 225.51M | 243.86M | 257.53M | |
Research & Development
| 78.36M | 96.91M | 105.50M | 108.96M | |
Other SG&A
| 111.07M | 128.60M | 138.36M | 148.57M | |
SGA Growth
| +19.05% | +19.05% | +8.14% | +5.61% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | 1.70M | - |
EBIT after Unusual Expense
| 212.36M | 265.80M | 210.79M | 117.61M | |
Non Operating Income/Expense
| (1.90M) | 18.15M | 24.94M | 26.00M | |
Non-Operating Interest Income
| 4.55M | 18.20M | 24.40M | 21.48M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 5.58M | 5.35M | 5.46M | 5.36M | |
Interest Expense Growth
| +15.33% | -4.11% | +2.15% | -1.79% | |
Gross Interest Expense
| 5.58M | 5.35M | 5.46M | 5.36M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 204.88M | 278.60M | 230.27M | 138.25M | |
Pretax Income Growth
| +70.13% | +35.98% | -17.35% | -39.96% | |
Pretax Margin
| +22.27% | +24.64% | +22.62% | +16.48% | |
Income Tax
| 21.81M | 32.34M | 29.28M | 18.01M | |
Income Tax - Current - Domestic
| 10.15M | 48.86M | 40.99M | 23.88M | |
Income Tax - Current - Foreign
| 3.12M | 3.50M | 3.89M | 4.82M | |
Income Tax - Deferred - Domestic
| 8.99M | (18.97M) | (13.55M) | (10.20M) | |
Income Tax - Deferred - Foreign
| (459.00K) | (1.05M) | (2.04M) | (498.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 183.08M | 246.26M | 200.99M | 120.24M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 183.08M | 246.26M | 200.99M | 120.24M | |
Net Income Growth
| +85.58% | +34.51% | -18.38% | -40.18% | |
Net Margin Growth
| +19.90% | +21.78% | +19.75% | +14.33% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 183.08M | 246.26M | 200.99M | 120.24M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 183.08M | 246.26M | 200.99M | 120.24M | |
EPS (Basic)
| 5.5406 | 7.5176 | 6.1745 | 3.8081 | |
EPS (Basic) Growth
| +88.46% | +35.68% | -17.87% | -38.33% | |
Basic Shares Outstanding
| 33.04M | 32.76M | 32.55M | 31.57M | |
EPS (Diluted)
| 5.4582 | 7.4254 | 6.1458 | 3.7968 | |
EPS (Diluted) Growth
| +89.60% | +36.04% | -17.23% | -38.22% | |
Diluted Shares Outstanding
| 33.54M | 33.16M | 32.70M | 31.67M | |
EBITDA
| 223.97M | 278.86M | 226.60M | 136.93M | |
EBITDA Growth
| +62.13% | +24.51% | -18.74% | -39.57% | |
EBITDA Margin
| +24.34% | +24.67% | +22.26% | +16.32% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 96.333 | |
| Number of Ratings | 7 | Current Quarters Estimate | 0.818 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 3.648 | |
| Last Quarter’s Earnings | 0.71 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 4.88 | Next Fiscal Year Estimate | 4.512 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 6 | 6 | 5 |
| Mean Estimate | 0.82 | 0.99 | 3.65 | 4.51 |
| High Estimates | 0.88 | 1.13 | 3.91 | 5.09 |
| Low Estimate | 0.68 | 0.75 | 2.97 | 3.87 |
| Coefficient of Variance | 8.59 | 12.97 | 9.53 | 12.19 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 2 |
| OVERWEIGHT | 1 | 1 | 0 |
| HOLD | 4 | 4 | 5 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Axcelis Technologies - ACLS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Axcelis Technologies - ACLS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 21, 2025 | Russell J. Low PRESIDENT AND CEO; Director | 137,142 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $61.58 per share | 8,445,204.36 |
| May 21, 2025 | Russell J. Low PRESIDENT AND CEO; Director | 136,155 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.01 per share | 8,442,971.55 |
| May 21, 2025 | Greg Redinbo EVP MARKETING AND APPLICATIONS | 33,603 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $61.58 per share | 2,069,272.74 |
| May 20, 2025 | Greg Redinbo EVP MARKETING AND APPLICATIONS | 33,970 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 2,128,899.90 |
| May 20, 2025 | Christopher Tatnall EVP Global Customer Operations | 24,441 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 1,531,717.47 |
| May 20, 2025 | Christopher Tatnall EVP Global Customer Operations | 24,611 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 1,542,371.37 |
| May 20, 2025 | Christopher Tatnall EVP Global Customer Operations | 24,956 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Christopher Tatnall EVP Global Customer Operations | 18,808 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Gerald M Blumenstock EVP, Research, Dev. & Eng. | 22,201 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 1,391,336.67 |
| May 20, 2025 | Gerald M Blumenstock EVP, Research, Dev. & Eng. | 22,546 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Gerald M Blumenstock EVP, Research, Dev. & Eng. | 16,398 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Greg Redinbo EVP MARKETING AND APPLICATIONS | 33,793 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 2,117,807.31 |
| May 20, 2025 | James G. Coogan EVP AND CFO | 27,936 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Greg Redinbo EVP MARKETING AND APPLICATIONS | 34,179 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Russell J. Low PRESIDENT AND CEO; Director | 137,854 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 8,639,310.18 |
| May 20, 2025 | Russell J. Low PRESIDENT AND CEO; Director | 139,307 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 8,730,369.69 |
| May 20, 2025 | James G. Coogan EVP AND CFO | 39,657 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $62.67 per share | 2,485,304.19 |
| May 20, 2025 | James G. Coogan EVP AND CFO | 40,231 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |